Human Kunitz-type protease inhibitor 2 (SPINT2) ELISA Kit

SPINT2 encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. Kunitz-type protease inhibitor 2 inhibits HGF activator which prevents the formation of active hepatocyte growth factor. SPINT2 is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for SPINT2.

SPINT2; DIAR3; FLJ45571; HAI-2; HAI2; Kop; PB; hepatocyte growth factor activator inhibitor type 2; placental bikunin; serine protease inhibitor; Kunitz type; 2

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Human Kunitz-type protease inhibitor 2 (SPINT2) ELISA Kit has high sensitivity and excellent specificity for detection of Human SPINT2. No significant cross-reactivity or interference between Human SPINT2 and analogues was observed.

This Human Kunitz-type protease inhibitor 2 (SPINT2) ELISA Kit employs a two-site sandwich ELISA to quantitate SPINT2 in samples. An antibody specific for SPINT2 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anySPINT2 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for SPINT2 is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of SPINT2 bound in the initial step. The color development is stopped and the intensity of the color is measured.

SPINT2; DIAR3; FLJ45571; HAI-2; HAI2; Kop; PB; hepatocyte growth factor activator inhibitor type 2; placental bikunin; serine protease inhibitor; Kunitz type; 2

• Do not mix components from different kit lots or use reagents beyond the kit expiration date.• Allow all reagents to warm to room temperature for at least 30 minutes before opening.• Pre-rinse the pipet tip with reagent, use fresh pipet tips for each sample, standard and reagent to avoid contamination.• Unused wells must be kept desiccated at 4 °C in the sealed bag provided.• Mix Thoroughly is very important for the result. It is recommended using low frequency oscillator or slight hand shaking every 10 minutes.• It is recommended that all samples and standards be assayed in duplicate or triplicate.